Neurology · Clinical Calculator · Acute Stroke

NIHSS NIH Stroke Scale — Severity in Acute Ischemic Stroke

The National Institutes of Health Stroke Scale (NIHSS) grades fifteen components of a focused neurologic exam — level of consciousness, gaze, visual fields, motor function, sensation, language, dysarthria, and neglect — for a summed score of 0 (no deficit) to 42 (severe stroke). It is the standard severity measure used at the bedside to track acute ischemic stroke and to inform decisions about intravenous thrombolysis and endovascular thrombectomy.

Published: References: 3 Read time:

← All calculators & tools  ·  ABCD² for TIA →

Instructions
  1. Perform the fifteen-item NIHSS examination in the order below; each item has a fixed set of scoring choices. Score what the patient does, not what you think the patient can do.
  2. If an item cannot be tested (for example, intubation, limb amputation, prior blindness), score it as the certification manual directs — do NOT leave it blank; the running total updates automatically as each item is set.
  3. Read the total score and the severity band. Repeat NIHSS after any treatment and at any change in neurologic status; serial scores drive thrombolysis, thrombectomy, and triage decisions.
  4. NIHSS is a severity measure, not a diagnosis. Integrate it with the time of onset (or last-known-well), imaging, blood pressure, glucose, contraindications, and current AHA/ASA 2019 guideline criteria before any reperfusion decision.

All computation runs in your browser; no values are stored or transmitted.

When to Use

Use the NIH Stroke Scale (NIHSS) for every patient with a known or suspected acute cerebrovascular event: in the emergency department during the first evaluation of possible acute ischemic stroke, after symptom change on the stroke unit, before and after reperfusion therapy, before and after interhospital transfer, and whenever the examiner needs a reproducible, numeric record of the deficit for handoff or research. A certified rater should ideally perform the examination, but any clinician trained in the scale can use it at the bedside.

✅

Appropriate population

Adults with acute focal neurologic symptoms consistent with ischemic stroke or transient ischemic attack, including patients being screened for intravenous alteplase or tenecteplase and for mechanical thrombectomy. Repeat serial NIHSS is standard for the first 24 hours and whenever there is a clinical change.

⚠️

When NOT to rely on it alone

NIHSS underweights the posterior circulation (vertebrobasilar, cerebellar, and pure brainstem strokes can present with low scores despite devastating deficits), right-hemisphere strokes (language items score zero even with hemineglect) and isolated vision loss. A low NIHSS never excludes a large vessel occlusion needing thrombectomy, and a high score does not itself establish the cause of the deficit. Pair the score with neuroimaging and the clinical trajectory.

Pearls & Pitfalls
💡

Score what you observe, not what you believe

The scale is defined by what the patient actually does during each test. Do not coach, do not estimate, and do not dock points for findings outside the scored item. If the patient does not attempt a task, score the "no effort" option; if the patient physically cannot attempt it (intubated, amputated, blind), follow the certification rules for untestable items.

🔬

Severity bands & reperfusion

Interpretation is directional, not absolute: 0 = no deficit, 1–4 = minor, 5–15 = moderate, 16–20 = moderate-to-severe, 21–42 = severe. Patients with low NIHSS below 5 can still benefit from alteplase if the deficit is disabling. Very high NIHSS (classically more than 25) is a relative caution for intra-arterial therapy in some institutional protocols but is not an absolute contraindication under current AHA/ASA 2019 guidance; use it to inform shared decision-making with the family and the stroke neurologist, not as an automatic gate.

🚫

Pitfalls

(1) A deceptively low NIHSS can accompany a large-vessel posterior-circulation occlusion — do not let the number override vascular imaging. (2) Inter-rater variability is highest for ataxia, dysarthria, and facial palsy; when in doubt, repeat the exam and document discordance. (3) Previous blindness, dense cataracts, severe dementia, aphasia from prior stroke or language barriers all distort individual items — follow the official NIHSS certification manual's rules for untestable or baseline-abnormal findings. (4) NIHSS is a static snapshot; a rapid rise or fall between exams is clinically more important than any single total score.

Why Use It

The NIHSS converts a complex neurologic examination into a single reproducible number that stroke teams, emergency physicians, and neurologists all understand. It is the severity measure used in the landmark reperfusion trials, is embedded in national and international guidelines, and drives decisions about intravenous thrombolysis, transfer for mechanical thrombectomy, admission to a stroke unit, and triage of nursing intensity. A serial NIHSS over the first 24 hours also captures neurologic deterioration earlier than a free-text note and documents treatment response for the team, the family, and the medical record.

NIH Stroke Scale (NIHSS)

Score each of the fifteen items in the order below. Each dropdown is pre-filled with 0; change only the items you have examined. The running total and severity band update automatically.

e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
e.g. 0
0
Total NIHSS
0–42
No deficit
Severity band
per Brott 1989
—
Reperfusion note
informational only

⚕ Brott T et al. Stroke. 1989;20(7):864–870. The NIHSS grades stroke severity; it does not diagnose the cause of the deficit or determine thrombolysis or thrombectomy eligibility on its own. For licensed clinicians; integrate with imaging, time of onset, blood pressure, glucose, contraindications, and current AHA/ASA 2019 guidance before any reperfusion decision.

Next Steps

Use the total NIHSS to describe severity, track change, and frame — not finalize — reperfusion decisions.

  • Score 0: no measurable deficit on NIHSS. The patient can still have had a stroke or TIA; proceed with urgent neuroimaging and vascular evaluation, especially if symptoms were transient.
  • Score 1–4 (minor): many such patients still benefit from intravenous thrombolysis when the deficit is disabling for them (dominant-hand weakness, aphasia, hemianopia, dense sensory loss). Do not use a low score to withhold alteplase when onset is within window and the deficit is disabling.
  • Score 5–15 (moderate): typical range for anterior-circulation stroke reaching the emergency department. Confirm candidacy for alteplase or tenecteplase and screen urgently for large-vessel occlusion with CT angiography; consider endovascular thrombectomy per AHA/ASA 2019 criteria.
  • Score 16–20 (moderate-to-severe): likely proximal large-vessel occlusion. Activate the thrombectomy pathway, control blood pressure to the target for the chosen therapy, and consider rapid transfer to a comprehensive stroke center.
  • Score 21–42 (severe): devastating deficit, often with impaired consciousness. Reperfusion may still be offered within window; simultaneously address airway, blood pressure, and glucose, and begin shared decision-making about goals of care while treatment is pursued. Scores greater than 25 are treated as a relative caution for intra-arterial therapy in some protocols but not an absolute contraindication under current AHA/ASA guidance.
  • Pair NIHSS with the ABCD² score when the event looks more like a TIA, and with the ICH Score if neuroimaging shows intracerebral hemorrhage.
Evidence & References

Scoring

ItemRangeWhat is graded
1a — Level of consciousness0–3Alert → unresponsive
1b — LOC questions0–2Month and age
1c — LOC commands0–2Open/close eyes, grip/release
2 — Best gaze0–2Horizontal eye movements
3 — Visual fields0–3Confrontation testing
4 — Facial palsy0–3Symmetry at rest and on movement
5a / 5b — Motor arm, left / right0–4 eachDrift test, 10 seconds
6a / 6b — Motor leg, left / right0–4 eachDrift test, 5 seconds at 30°
7 — Limb ataxia0–2Finger-to-nose, heel-to-shin
8 — Sensory0–2Pinprick response
9 — Best language0–3Fluency and comprehension
10 — Dysarthria0–2Articulation
11 — Extinction / inattention0–2Neglect by any modality
Total0–42Sum of all items

Severity bands (Brott 1989)

Total NIHSSBand
0No stroke symptoms
1–4Minor stroke
5–15Moderate stroke
16–20Moderate to severe stroke
21–42Severe stroke

The NIHSS was derived at the University of Cincinnati stroke program as a reproducible bedside quantification of ischemic-stroke deficits, refined in the NINDS tPA trial, and is now embedded in AHA/ASA acute-stroke guidance as the standard severity measure.

References

  1. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–870. doi:10.1161/01.STR.20.7.864.
  2. Lyden P. Using the National Institutes of Health Stroke Scale: a cautionary tale. Stroke. 2017;48(2):513–519. doi:10.1161/STROKEAHA.116.015434.
  3. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211.
Important: The NIH Stroke Scale is an educational aid for licensed clinicians and does not replace an individualized neurologic examination. NIHSS grades severity in acute ischemic stroke; it does not establish the cause of the deficit, does not substitute for neuroimaging, and does not by itself determine eligibility for intravenous thrombolysis or endovascular thrombectomy. A low score never excludes a large-vessel occlusion, and a high score does not itself preclude treatment. Always integrate the result with onset time, imaging, blood pressure, glucose, contraindications, and current AHA/ASA 2019 guidance and institutional protocols before any reperfusion decision.
References 3 sources
  1. Brott, T., Adams, H. P., Jr., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., Hertzberg, V., Rorick, M., Moomaw, C. J., & Walker, M. (1989). Measurements of acute cerebral infarction: A clinical examination scale. Stroke, 20(7), 864–870. https://doi.org/10.1161/01.STR.20.7.864
  2. Lyden, P. (2017). Using the National Institutes of Health Stroke Scale: A cautionary tale. Stroke, 48(2), 513–519. https://doi.org/10.1161/STROKEAHA.116.015434
  3. Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., Jauch, E. C., Kidwell, C. S., Leslie-Mazwi, T. M., Ovbiagele, B., Scott, P. A., Sheth, K. N., Southerland, A. M., Summers, D. V., & Tirschwell, D. L. (2019). Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke, 50(12), e344–e418. https://doi.org/10.1161/STR.0000000000000211
Dr. W Rivero, MD

W Rivero, MD, FPCP, DPSN

Specialist in Internal Medicine, Nephrology, and Clinical Nutrition. Practicing integrative and evidence-based nephrology across Quezon City, Pampanga, and Bulacan.

· Book an Appointment →

QR code — scan to save Dr. Rivero's contact info

Scan and save

All Calculators Related Guides